'Tim­ing could­n't be bet­ter': An ex-gener­ics mak­er goes SPAC route with blank check in­tend­ed for sports mar­ket

Dave Mehal­ick orig­i­nal­ly planned for his com­pa­ny to be a gener­ics mak­er with five drugs in the hop­per. But quick­ly af­ter found­ing Co­ep­tis Ther­a­peu­tics in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER